PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.21%
Revenue growth similar to MCHP's 10.82%. Walter Schloss would see if both companies share industry tailwinds.
21.35%
Gross profit growth 1.25-1.5x MCHP's 15.09%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
103.17%
EBIT growth 50-75% of MCHP's 140.04%. Martin Whitman would suspect suboptimal resource allocation.
103.17%
Operating income growth at 75-90% of MCHP's 132.00%. Bill Ackman would demand a plan to enhance operating leverage.
80.00%
Net income growth comparable to MCHP's 87.97%. Walter Schloss might see both following similar market or cost trajectories.
66.67%
EPS growth similar to MCHP's 70.34%. Walter Schloss would assume both have parallel share structures and profit trends.
66.67%
Similar diluted EPS growth to MCHP's 70.34%. Walter Schloss might see standard sector or cyclical influences on both firms.
30.34%
Share count expansion well above MCHP's 0.33%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
30.34%
Diluted share count expanding well above MCHP's 0.33%. Michael Burry would fear significant dilution to existing owners' stakes.
-26.23%
Dividend reduction while MCHP stands at 10.17%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
1562.50%
OCF growth above 1.5x MCHP's 33.85%. David Dodd would confirm a clear edge in underlying cash generation.
163.89%
FCF growth above 1.5x MCHP's 34.43%. David Dodd would verify if the firm’s strategic investments yield superior returns.
44.03%
10Y revenue/share CAGR at 75-90% of MCHP's 51.09%. Bill Ackman would press for new markets or product lines to narrow the gap.
33.59%
Positive 5Y CAGR while MCHP is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
17.30%
Positive 3Y CAGR while MCHP is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
461.80%
Positive 10Y CAGR while MCHP is negative. John Neff might see a substantial advantage in bottom-line trajectory.
43.62%
Positive 5Y CAGR while MCHP is negative. John Neff might view this as a strong mid-term relative advantage.
-30.51%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
90.48%
10Y dividend/share CAGR at 50-75% of MCHP's 180.63%. Martin Whitman suspects the firm lags in returning cash to shareholders over the decade.
76.37%
Below 50% of MCHP's 175.02%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
76.37%
3Y dividend/share CAGR similar to MCHP's 81.65%. Walter Schloss finds parallel short-term dividend strategies for both companies.
25.69%
AR growth well above MCHP's 10.99%. Michael Burry fears inflated revenue or higher default risk in the near future.
-2.17%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
7.24%
Positive asset growth while MCHP is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-21.23%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
19.09%
We have some new debt while MCHP reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
4.56%
SG&A growth well above MCHP's 4.80%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.